Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis(2,6-dioxopiperazine). The MST-16 Study Group (Q33494005)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis(2,6-dioxopiperazine). The MST-16 Study Group |
scientific article |
Statements
1 reference
Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis(2,6-dioxopiperazine). The MST-16 Study Group (English)
1 reference
Ohno R
1 reference
Masaoka T
1 reference
Shirakawa S
1 reference
Sakamoto S
1 reference
Hirano M
1 reference
Hanada S
1 reference
Yasunaga K
1 reference
Yokomaku S
1 reference
Mitomo Y
1 reference
Nagai K
1 reference